Gene: ARHGAP1
Official Full Name: Rho GTPase activating protein 1provided by HGNC
Gene Summary: This gene encodes a member of a large family of proteins that activate Rho-type guanosine triphosphate (GTP) metabolizing enzymes. The encoded protein contains a SRC homology 3 domain and interacts with Bcl-2-associated protein family members. [provided by RefSeq, Aug 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO38941 | ARHGAP1 Knockout cell line (HeLa) | Human | ARHGAP1 | 1:3~1:6 | Negative | Online Inquiry |
KO38942 | ARHGAP1 Knockout cell line (HCT 116) | Human | ARHGAP1 | 1:2~1:4 | Negative | Online Inquiry |
KO38943 | ARHGAP1 Knockout cell line (HEK293) | Human | ARHGAP1 | 1:3~1:6 | Negative | Online Inquiry |
KO38944 | ARHGAP1 Knockout cell line (A549) | Human | ARHGAP1 | 1:3~1:4 | Negative | Online Inquiry |
ARHGAP1 Gene Knockout Cell Lines are sophisticated biological tools designed to facilitate research in cellular signaling and molecular biology. These cell lines have been engineered to specifically inhibit the activity of the ARHGAP1 gene, which encodes a Rho GTPase-activating protein involved in the regulation of the actin cytoskeleton and cell motility. By creating a knockout model for ARHGAP1, researchers can investigate its role in various physiological processes and disease states, such as cancer metastasis and neurological disorders.
The key function of these cell lines lies in their ability to mimic a loss-of-function scenario for ARHGAP1, enabling the study of downstream effects on Rho GTPase signaling pathways. Through techniques such as quantitative PCR, Western blotting, and live-cell imaging, scientists can elucidate the alterations in cellular behavior, including changes in adhesion, migration, and proliferation rates. This functional insight is invaluable for understanding the underlying mechanisms of pathologies associated with dysregulated cell signaling.
In scientific research and clinical applications, ARHGAP1 Gene Knockout Cell Lines serve as a crucial platform for discovering new therapeutic targets and testing potential interventions. Their utility extends to drug screening assays and preclinical studies aimed at improving treatment outcomes for diseases influenced by Rho GTPase signaling.
What sets these cell lines apart from alternatives is their specificity and the validated methodology used for gene knockout. Unlike traditional knockdown approaches that may leave residual gene expression, our knockout model provides a complete loss of the target gene, ensuring the reliability of experimental outcomes. Additionally, the cell lines have been rigorously characterized for consistent performance and reproducibility, qualities that are imperative for high-quality research.
For researchers and clinicians, these cell lines represent a significant advancement in molecular tools, offering the potential to uncover novel insights and develop innovative therapies. By leveraging our extensive expertise in genetic engineering and cellular biology, our company is dedicated to providing researchers with high-performance products that meet the rigorous demands of contemporary scientific inquiry.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.